ACE Inhibition and Diabetic Nephropathy

BMJ
doi 10.1136/bmj.303.6814.1400-b
Full Text
Abstract

Available in full text

Date
Authors
Publisher

BMJ

Related search

ACE Inhibition and Diabetic Nephropathy: Author's Reply

BMJ
1991English

Inhibition of RAS in Diabetic Nephropathy

International Journal of Nephrology and Renovascular Disease
Nephrology
2015English

Research Article ACE Insertion/Deletion Polymorphism and Diabetic Nephropathy: An Evidence-Based Meta-Analysis

Genetics and Molecular Research
MedicineGeneticsMolecular Biology
2019English

ACE-inhibitors but Not Endothelin Receptor Blockers Prevent Podocyte Loss in Early Diabetic Nephropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2003English

EGFR Inhibition Attenuates Diabetic Nephropathy Through Decreasing ROS and Endoplasmic Reticulum Stress

Oncotarget
Oncology
2017English

Angiopoietins and Diabetic Nephropathy

Diabetologia
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Inhibition of Ceramide Accumulation in Podocytes by Myriocin Prevents Diabetic Nephropathy

Diabetes and Metabolism Journal
EndocrinologyMetabolismDiabetes
2019English

Relations Between ACE Gene and ecNOS Gene Polymorphisms and Resistive Index in Type 2 Diabetic Patients With Nephropathy

Diabetes Care
Internal MedicineEndocrinologyAdvancedMetabolismSpecialized NursingDiabetes
2001English

Errata: Hypertension and Diabetic Nephropathy

Experimental and Clinical Endocrinology and Diabetes
Internal MedicineMedicineDiabetesMetabolismEndocrinology
2016English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2026 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy